SpaceX Stock Is Down 26% From Its Post-IPO High. History Says a $20,000 Investment Will Be Worth This Much by Mid-2027.

SpaceX stock, after a 50% pop in its first three days, is down 26% to ~$150 amid concerns over a recent bond offering and upcoming lockup expirations. With only <5% of shares currently available, lockups could increase the float to ~1.5B shares by late July/early August (at least +20% of early-release shares) and to at least ~3B by late October (+7% additional early-release shares), raising likely sell-side pressure. The article models downside of ~11% (to ~$132) versus the IPO price baseline or ~30% (to ~$104 if a 23% first-year drawdown occurs), while noting the valuation is very stretched at ~101x sales.

Analysis

The setup is less about operating execution and more about marginal supply. When a name trades at an extreme sales multiple while most holders are still locked, price can be supported by scarcity rather than fundamentals; once that scarcity fades, the multiple often compresses faster than revenue can grow into it. That creates a classic post-IPO air pocket: the first move is driven by enthusiasm, the next move is driven by who has to sell.

Second-order, this can pressure the whole speculative growth complex. A large, headline-grabbing float expansion tends to suck up risk capital and attention from adjacent retail-favored names, which is a small negative for COIN, HOOD, SNOW, RIVN, and even high-beta software/consumer growth baskets if the tape turns risk-off. The bigger issue is not direct competition but relative valuation discipline: once investors have a fresh, very expensive benchmark, everything else with a premium multiple gets re-underwritten.

The key falsifier is a catalyst that creates durable new demand before the supply overhang hits: a credible profitability inflection, a strategic secondary buyer, or unexpectedly limited insider selling. Absent that, the next 1-3 months are a technical event window, while the 6-18 month outcome depends on whether the company can grow into a valuation that leaves no room for execution mistakes. In contrast to the crowd, I think the market is still underestimating how much the lockup calendar matters versus the business narrative.

Key Decisions for Investors

• Short SPCX into the first major lockup window; best entry is on any post-earnings strength, with a 1-3 month horizon and a thesis that float expansion will overwhelm scarcity-driven valuation.
• If listed options/borrow are available, buy SPCX puts or put spreads targeting the late-summer/early-fall unlock sequence; structure for a 20-30% downside move with defined risk rather than outright naked shorting.
• Pair trade: short SPCX against a long basket of profitable megacap growth (e.g., META/NVDA) to isolate supply-overhang risk from market beta; this should outperform if the tape stays constructive but speculative multiples compress.
• Watch COIN, HOOD, and SNOW for sympathy weakness in the 2-6 week window; if they underperform QQQ by more than 5-7% on no fundamental news, that confirms the retail-risk appetite thesis and supports keeping the SPCX short.